Sign in
CompletedNo phase

More Individualized Care: Assessment and Recovery Through Engagement

Key facts

Who runs it
Kaiser Permanente
Where
Indianapolis and Seattle, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
805 people enrolled
Started
10 Nov 2021
Ended
28 Feb 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • More Individualized Care: Assessment and Recovery through Engagement (MI-CARE)
Record updated
30 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Eligible patients must meet all 4 criteria:
  • ≥1 in person or virtual encounter in a primary care setting in the 365 days prior to the data extraction date (pull date)
  • Age ≥18 years at the pull date
  • ≥1 PHQ-9 depression screening score of ≥10 within the 7 days prior to the pull date
  • Evidence of potential OUD in the 365 days prior to and including the date of the qualifying PHQ-9 score. Any 1 of the following qualifies as evidence of potential OUD:; ≥1 active OUD ICD-10 diagnosis code in any setting except labs; ≥1 prescription (orders or dispensed) for buprenorphine (oral formulations indicated for OUD, extended release injectable, and implant); ≥1 procedure code for buprenorphine (oral formulations indicated for OUD, extended release injectable, and implant); ≥1 ICD-10 codes for opioid overdose; ≥1 OUD ICD-10 code, including remission, and prescription (orders or dispensed) or procedure code for injectable naltrexone

Who cannot take part

  • Any one of the following conditions in the 2 years prior to and including the date of the qualifying PHQ:; Alzheimer's disease or dementia diagnosis, or medication to treat Alzheimer's or dementia; Severe cognitive limitations
  • Previously requested to not participate in research studies at the health system
  • Documentation of hospice care in the 2 years prior to and including the date of the qualifying PHQ score
  • Current active treatment for cancer with chemotherapy or radiation therapy in the past 3 months (not including non-melanoma skin cancers)
  • Patients are ineligible who meet any of the criteria below:
  • The only indication of OUD or only PHQ available to determine eligibility came from data protected under 42 CFR Part 2
  • The patient has already been randomized to the trial or was outreached in the pilot study (including outreach to the primary care provider only)
  • English interpreter required (per health system records)
  • Patient is actively being outreached for (or is participating in) depression care management (Kaiser Permanente Washington only)

Where in United States

  • Indiana University HealthIndianapolis, United States
  • Kaiser Permanente Washington Health Research InstituteSeattle, United States

About the trial

What the trial wants to find out

The MI-CARE trial tests 12 months of telephone-based nurse care management for patients with depressive symptoms who take or have taken opioids at some time. The study tests whether offering nurse support to the patient and their primary care team that addresses these things and related issues can improve patients' health and well-being. Eligible subjects are identified automatically using health system data and randomly assigned 50:50 to either a no-contact usual care arm or to the arm offered the MI-CARE program.

The 2 groups in the trial

  • MI-CARE programTreatment being tested

    Those automatically identified as eligible and randomized to the MI-CARE arm are outreached by a study nurse care manager and offered the 12-month long virtual Collaborative Care program by telephone or video visits. Individuals are free to accept or decline the offer (e.g., stop/restart, not accept right away) during the 12 months after their randomization date.

    Treatment: More Individualized Care: Assessment and Recovery through Engagement (MI-CARE)

  • Usual careNo study treatment, for comparison

    Those identified as eligible and randomized to the usual care arm have no contact with the study. All outcome data for both study arms are collected from secondary, electronic sources.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Patient-centered Team-based Primary Care to Treat Opioid Use Disorder, Depression, and Other Conditions
Publications
Record updated
30 March 2026